LXRX
LEXICON PHARMACEUTICALS, INC.
+0.08 (+4.21%)2.11USD1.1M成交股數937M市值–本益比(近四季)22.6股價營收比-97.6%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 692K-98% | 21.1M+1572% | 5.5M+216% | 14.2M+777% | 28.9M+2541% | 1.3M+88% | 1.7M+1076% | 1.6M+456% | 1.1M | 671K | 148K | 291K |
| 營業成本 | 39K | 108K | 201K | 10K | 33K | 30K | 71K | 166K | 31K | 70K | 7K | 8K |
| 毛利 | 653K-98% | 21.0M+1604% | 5.3M+217% | 14.2M+877% | 28.8M+2615% | 1.2M+105% | 1.7M+1084% | 1.5M+413% | 1.1M | 601K | 141K | 283K |
| 毛利率 | 94.4% | 99.5% | 96.3% | 99.9% | 99.9% | 97.6% | 95.9% | 89.7% | 97.2% | 89.6% | 95.3% | 97.3% |
| 研發費用 | 17.4M | 12.8M | 11.3M | 18.8M | 15.7M | 15.3M | 25.8M | 17.6M | 14.4M | 14.8M | 17.6M | 14.5M |
| 銷售管理費用 | 9.8M | 9.2M | 8.8M | 7.6M | 9.4M | 11.6M | 39.6M | 39.2M | 32.1M | 32.6M | 32.2M | 30.0M |
| 營業利益 | −26.5M-810% | −996K-96% | −14.8M-77% | −12.2M-78% | 3.7M-108% | −25.7M-45% | −63.7M+28% | −55.4M+25% | −45.3M | −46.7M | −49.6M | −44.2M |
| 營業利益率 | -3,835.3% | -4.7% | -269.1% | -85.9% | 12.9% | -2,034.8% | -3,658.4% | -3,423.3% | -4,147.6% | -6,965.3% | -33,534.5% | -15,202.7% |
| 稅後淨利 | −31.8M-1077% | −1.0M-96% | −15.5M-76% | −12.8M-76% | 3.3M-107% | −25.3M-49% | −64.8M+28% | −53.4M+19% | −48.4M | −49.8M | −50.5M | −44.9M |
| 淨利率 | -4,591.8% | -4.9% | -282.7% | -90.0% | 11.3% | -2,004.4% | -3,722.6% | -3,304.2% | -4,427.9% | -7,415.2% | -34,138.5% | -15,430.9% |
| 稀釋 EPS | -0.07-800% | 0.00-100% | -0.04-78% | -0.04-76% | 0.01-105% | -0.07-65% | -0.18-14% | -0.17-23% | -0.20 | -0.20 | -0.21 | -0.22 |
| 稀釋股數 | 438M | 400M | 363M | 363M | 364M | 362M | 361M | 311M | 245M | 221M | 245M | 205M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 40.9M | 38.1M | 34.3M | 49.7M | 21.4M | 62.9M | 34.6M | 35.6M | 96.5M | 22.5M | 21.1M | 102M |
| 應收帳款 | 1.6M | 11.8M | 2.4M | 2.3M | 2.2M | 47.4M | 2.9M | 2.6M | 1.5M | 1.0M | 318K | 685K |
| 存貨 | 1.2M | 276K | 281K | 158K | 168K | 201K | 636K | 585K | 514K | 381K | 336K | 172K |
| 總資產 | 250M | 269M | 185M | 206M | 226M | 298M | 321M | 373M | 417M | 229M | 276M | 317M |
| 有息負債 | 51.4M | 49.7M | 49.4M | 56.5M | 56.1M | 58.6M | 99.9M | 99.5M | 99.9M | 99.5M | 99.3M | 98.8M |
| 總負債 | 75.5M | 66.0M | 77.4M | 85.8M | 96.1M | 175M | 143M | 133M | 128M | 136M | 137M | 130M |
| 股東權益 | 175M | 203M | 108M | 120M | 129M | 123M | 179M | 240M | 289M | 93.1M | 140M | 186M |
| 負債比 | 30.2% | 24.5% | 41.9% | 41.6% | 42.6% | 58.7% | 44.4% | 35.7% | 30.8% | 59.4% | 49.5% | 41.2% |
| 淨現金(現金 − 有息負債) | −10.5M | −11.6M | −15.1M | −6.9M | −34.7M | 4.2M | −65.3M | −63.9M | −3.4M | −77.0M | −78.1M | 3.5M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −14.7M-66% | – | – | – | −43.8M | – | – | −55.1M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | 0.00 | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −55.1M | – | – | – |
| 折舊攤銷 | – | 110K | – | – | – | 176K | – | – | 144K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | 1.7M | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -5,043.9% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 49.8M
| Reportable | 49.8M | 100.0% | +60.2% |
|---|
產品／服務2025 年度 · 49.6M
| License | 45.0M | 90.6% | +80.0% |
|---|---|---|---|
| 產品 | 4.6M | 9.4% | -22.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 49.8M | +729.9% | −50.3M | -101.1% | -0.14 | −67.9M |
| FY2024 | 6.0M | +440.6% | −200M | -3,339.5% | -0.63 | −180M |
| FY2023 | 1.1M | – | −177M | -15,956.7% | -0.80 | −162M |
| FY2022 | 0.00 | – | −102M | –% | -0.62 | −90.2M |
| FY2021 | 0.00 | -100.0% | −87.8M | –% | -0.60 | −88.2M |
| FY2020 | 23.4M | -27.6% | −58.6M | -250.3% | -0.53 | −143M |
| FY2019 | 32.3M | +21.6% | 130M | 402.5% | 1.16 | 114M |
| FY2018 | 26.6M | – | −121M | -453.5% | -1.14 | −149M |